Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serology), By User (Single v/s Multiple), By Full Test Time (Less Than 60 Minutes, 1 Hour - 12 Hours, 13 Hours - 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs, P

Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serology), By User (Single v/s Multiple), By Full Test Time (Less Than 60 Minutes, 1 Hour - 12 Hours, 13 Hours - 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others), By Region, Competition, Forecast & Opportunities, 2025

The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. First case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 9th April 2020, the total number of coronavirus cases crossed 1.5 million, globally, of which around 330,000 had recovered and over 88,000 people had died.

Global coronavirus diagnostics market is expected to grow at a CAGR of more than 12% during 2015-2025. The global coronavirus diagnostics market is driven by surging incidences of this disease across different parts of the globe. The market is segmented based on type of test, user, full test time, end user, company and region. Based on type of test, market can be bifurcated into molecular and serological tests. The molecular type of test segment is expected to dominate the market during forecast period. In this testing procedure, a sample from the back of the throat is taken and sent for testing. The sample undergoes a PCR test to find out the presence of virus genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of SARS-COV-2 virus.

Europe and North America are expected to witness significant growth during the forecast period owing to the presence of many research laboratories and pharmaceutical & biotechnology companies across the regions. Major players operating in the coronavirus diagnostics market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd., Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., and others.
Years considered for this report:
Historical Year: 2015-2018
Base Year: 2019
Estimated Year: 2020E
Forecast Period: 2021–2025
Objective of the Study:
To estimate and forecast the market size of global coronavirus diagnostics market from 2015 to 2025F.
To classify and forecast global coronavirus diagnostics market based on type of test, user, full test time, end user, company and regional distribution.
To identify dominant regions and segments in the global coronavirus diagnostics market.
To identify drivers and challenges for global coronavirus diagnostics market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus diagnostics market.
To identify and analyze the profile of leading players operating in global coronavirus diagnostics market.
To identify key sustainable strategies adopted by market players in global coronavirus diagnostics market.


TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of diagnostic players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the market players which could not be identified due to the limitations of secondary research.
TechSci Research calculated the market size of global coronavirus diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
Coronavirus diagnostic kits manufacturers, suppliers, distributors and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to coronavirus diagnostics
Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders, besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global coronavirus diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Market, By Type of Test:
Molecular
Serology
Market, By User:
Single
Multiple
Market, By Full Test Time:
Less Than 60 Minutes
1 Hour - 12 Hours
13 Hours - 24Hours
More Than 1 Day
Market, By End User:
Hospitals
Public Health Labs
Private or Commercial Labs
Physician Labs
Others
Market, By Region:
North America
United States
Canada
Mexico
Europe
Russia
Germany
France
United Kingdom
Italy
Spain
Asia-Pacific
China
Japan
India
South Korea
Australia
Thailand
Singapore
Middle East & Africa
South Africa
Saudi Arabia
UAE
Iran
South America
Brazil
Argentina
Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global coronavirus diagnostics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
4.1. Brand Awareness (Aided/Unaided)
4.2. Product Awareness
4.3. Customer Satisfaction Analysis
4.4. Pricing Analysis
4.5. Unmet Needs/Challenges
5. Global Coronavirus Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Test (Molecular v/s Serology)
5.2.2. By User (Single v/s Multiple)
5.2.3. By Full Test Time (Less Than 60 Minutes, 1 Hours to 12 Hours, 13 Hours-24Hours, More Than 1 Days)
5.2.4. By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)
5.2.5. By Company (2020)
5.2.6. By Region
5.3. Product Market Map
6. Europe Coronavirus Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Test
6.2.2. By User
6.2.3. By End User
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. Russia Coronavirus Diagnostics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Test
6.3.1.2.2. By User
6.3.1.2.3. By End User
6.3.2. Italy Coronavirus Diagnostics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Test
6.3.2.2.2. By User
6.3.2.2.3. By End User
6.3.3. Spain Coronavirus Diagnostics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Test
6.3.3.2.2. By User
6.3.3.2.3. By End User
6.3.4. Germany Coronavirus Diagnostics Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type of Test
6.3.4.2.2. By User
6.3.4.2.3. By End User
6.3.5. France Coronavirus Diagnostics Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type of Test
6.3.5.2.2. By User
6.3.5.2.3. By End User
6.3.6. United Kingdom Coronavirus Diagnostics Market Outlook
6.3.6.1. Market Size & Forecast
6.3.6.1.1. By Value
6.3.6.2. Market Share & Forecast
6.3.6.2.1. By Type of Test
6.3.6.2.2. By User
6.3.6.2.3. By End User
7. North America Coronavirus Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Test
7.2.2. By User
7.2.3. By End User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Coronavirus Diagnostics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Test
7.3.1.2.2. By User
7.3.1.2.3. By End User
7.3.2. Canada Coronavirus Diagnostics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Test
7.3.2.2.2. By User
7.3.2.2.3. By End User
7.3.3. Mexico Coronavirus Diagnostics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Test
7.3.3.2.2. By User
7.3.3.2.3. By End User
7.3.3.2.4.
8. Asia-Pacific Coronavirus Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Test
8.2.2. By User
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Coronavirus Diagnostics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Test
8.3.1.2.2. By User
8.3.1.2.3. By End User
8.3.2. South Korea Coronavirus Diagnostics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Test
8.3.2.2.2. By User
8.3.2.2.3. By End User
8.3.3. Australia Coronavirus Diagnostics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Test
8.3.3.2.2. By User
8.3.3.2.3. By End User
8.3.4. India Coronavirus Diagnostics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Test
8.3.4.2.2. By User
8.3.4.2.3. By End User
8.3.5. Japan Coronavirus Diagnostics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Test
8.3.5.2.2. By User
8.3.5.2.3. By End User
8.3.6. Thailand Coronavirus Diagnostics Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Type of Test
8.3.6.2.2. By User
8.3.6.2.3. By End User
8.3.7. Singapore Coronavirus Diagnostics Market Outlook
8.3.7.1. Market Size & Forecast
8.3.7.1.1. By Value
8.3.7.2. Market Share & Forecast
8.3.7.2.1. By Type of Test
8.3.7.2.2. By User
8.3.7.2.3. By End User
9. Middle East and Africa Coronavirus Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Test
9.2.2. By User
9.2.3. By End User
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. Iran Coronavirus Diagnostics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Test
9.3.1.2.2. By User
9.3.1.2.3. By End User
9.3.2. UAE Coronavirus Diagnostics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Test
9.3.2.2.2. By User
9.3.2.2.3. By End User
9.3.3. Saudi Arabia Coronavirus Diagnostics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Test
9.3.3.2.2. By User
9.3.3.2.3. By End User
9.3.4. South Africa Coronavirus Diagnostics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type of Test
9.3.4.2.2. By User
9.3.4.2.3. By End User
10. South America Coronavirus Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Test
10.2.2. By User
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Coronavirus Diagnostics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Test
10.3.1.2.2. By User
10.3.1.2.3. By End User
10.3.2. Argentina Coronavirus Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Test
10.3.2.2.2. By User
10.3.2.2.3. By End User
10.3.3. Colombia Coronavirus Diagnostics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Test
10.3.3.2.2. By User
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Abbott Laboratories
13.2. Altona Diagnostics GmbH
13.3. BioMerieux SA
13.4. Bio-Rad Laboratories, Inc.
13.5. Danaher Corporation
13.6. F.Hoffmann-La Roche Ltd
13.7. GSK Biologicals SA
13.8. Mylab Discovery Solutions Pvt. Ltd.
13.9. Seegene Inc.
13.10. Siemens AG
13.11. Thermo Fisher Scientific Inc.
14. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook